𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical development of S-1 plus cisplatin therapy as first-line treatment for advanced gastric cancer

✍ Scribed by Wasaburo Koizumi

Publisher
Springer
Year
2009
Tongue
English
Weight
171 KB
Volume
12
Category
Article
ISSN
1436-3291

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Impacts of fluorouracil-metabolizing enz
Impacts of fluorouracil-metabolizing enzymes on the outcomes of patients treated with S-1 alone or S-1 plus cisplatin for first-line treatment of advanced gastric cancer
✍ Wasaburo Koizumi; Satoshi Tanabe; Mizutomo Azuma; Kenji Ishido; Ken Nishimura; T πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 267 KB

## Abstract A phase III trial of S‐1 plus cisplatin (SP) __versus__ S‐1 alone, for first‐line treatment of advanced gastric cancer (SPIRITS trial), has shown that overall survival was better in patients treated with SP than with S‐1 alone. In the present retrospective biomarker study, we aimed to d